Market Eyes LiveThermo Fisher Scientific, Inc. (TMO) Stock Rating & Analysis
MELANY's data-driven read on Thermo Fisher Scientific, Inc. · Measuring & Controlling Devices, Nec.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. As of year-end 2025 it operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (17% of sales), specialty diagnostic products (11%), life science solutions (23%), and lab products and services, which includes CRO services and makes up the remainder.
Why TMO scores 58/100
MELANY scores Thermo Fisher Scientific, Inc. 58/100 by weighing eight factors. Here is how TMO breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Forward P/E 22.8x, earnings growth accelerating
Margins, returns on capital, and balance-sheet strength.
- Gross margin 41%
Direction and relative strength of the recent share-price trend.
- Price +16.5% above 50-day MA
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
Key risks for TMO
- Trading near 52-week high, limited upside without new positive catalyst
Sector and theme context
Thermo Fisher Scientific, Inc. sits in the Healthcare sector theme, which MELANY currently rates 42/100 for strength. Theme strength feeds TMO's momentum and catalyst factors above.
Tracking TMO
Thermo Fisher Scientific, Inc. rates Hold right now, so MELANY is not flagging a fresh entry. Create a free account to add TMO to your watchlist and get alerted the moment the rating changes.
How MELANY rates TMO
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Thermo Fisher Scientific, Inc.'s 58/100 reflects mature factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about TMO
Is Thermo Fisher Scientific, Inc. (TMO) a buy?
As of 2026-08-20, MELANY rated Thermo Fisher Scientific, Inc. Hold with a composite score of 58/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Thermo Fisher Scientific, Inc.'s MELANY score?
Thermo Fisher Scientific, Inc. (TMO) has a MELANY composite score of 58/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, and macro fit.
How is the TMO stock rating calculated?
MELANY scores TMO from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Thermo Fisher Scientific, Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Thermo Fisher Scientific, Inc. (TMO) Hold with a composite of 58/100 as of 2026-08-20. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the TMO stock price forecast?
MELANY does not publish price targets or forecasts for TMO. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 58/100 across eight factors for Thermo Fisher Scientific, Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is TMO stock overvalued or undervalued?
MELANY's valuation factor currently reads 43/100 for Thermo Fisher Scientific, Inc., where a higher score means the price looks more attractive against earnings, growth, and peers. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives TMO's read.
What price should I buy TMO at?
MELANY is not flagging a fresh entry for TMO at its current Hold rating, so there is no entry zone to publish right now. Watchlisting TMO in the free app gets you alerted the moment that changes.
What are the risks of buying TMO stock?
The top risks MELANY currently flags for Thermo Fisher Scientific, Inc.: Trading near 52-week high, limited upside without new positive catalyst. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Thermo Fisher Scientific, Inc. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 55/100 for Thermo Fisher Scientific, Inc., and earnings track record, at 76/100. The 58/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will TMO stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 71/100 for TMO right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this TMO rating?
The rating on this page is a snapshot of MELANY's read as of 2026-08-20. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores TMO continuously as new price, earnings, and fundamental data arrive, and that current rating is free in the app.
TMO's live rating and alerts are free either way. The app is our flagship.